Barbara S. Slusher

20.7k total citations · 5 hit papers
316 papers, 15.4k citations indexed

About

Barbara S. Slusher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Barbara S. Slusher has authored 316 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Molecular Biology, 109 papers in Cellular and Molecular Neuroscience and 62 papers in Oncology. Recurrent topics in Barbara S. Slusher's work include Neuropeptides and Animal Physiology (56 papers), Neuroscience and Neuropharmacology Research (51 papers) and Peptidase Inhibition and Analysis (33 papers). Barbara S. Slusher is often cited by papers focused on Neuropeptides and Animal Physiology (56 papers), Neuroscience and Neuropharmacology Research (51 papers) and Peptidase Inhibition and Analysis (33 papers). Barbara S. Slusher collaborates with scholars based in United States, Czechia and Japan. Barbara S. Slusher's co-authors include Camilo Rojas, Ajit G. Thomas, Takashi Tsukamoto, Rana Rais, Jesse Alt, Krystyna M. Wozniak, Brent R. Stockwell, Pavel Majer, Miki Hayano and Eric D. Lee and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Barbara S. Slusher

307 papers receiving 15.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis

2014 1.6k citations Ajit G. Thomas, Barbara S. Slusher et al. profile →
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

2012 886 citations Takashi Tsukamoto, Barbara S. Slusher et al. profile →
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

2019 813 citations Robert D. Leone, Liang Zhao et al. Science profile →
HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

2016 760 citations Norman J. Haughey, Barbara S. Slusher et al. profile →
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

2020 323 citations Min Hee Oh, Im‐Hong Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara S. Slusher United States	58	7.2k	3.5k	2.7k	2.7k	2.4k	316	15.4k
Catriona McLean Australia	69	7.1k 1.0×	1.2k 0.3×	1.5k 0.5×	2.4k 0.9×	2.3k 0.9×	471	19.5k
Dudley K. Strickland United States	75	8.7k 1.2×	5.5k 1.6×	1.5k 0.5×	2.0k 0.7×	2.4k 1.0×	257	21.3k
Craig J. Thomas United States	61	7.0k 1.0×	1.9k 0.5×	764 0.3×	1.8k 0.7×	1.6k 0.7×	250	15.2k
Len Neckers United States	85	19.4k 2.7×	3.0k 0.9×	1.9k 0.7×	931 0.3×	3.1k 1.3×	248	24.9k
Richard F. Keep United States	82	7.4k 1.0×	1.1k 0.3×	1.4k 0.5×	3.3k 1.2×	1.6k 0.7×	418	25.0k
Philip A. Cole United States	75	17.2k 2.4×	1.5k 0.4×	985 0.4×	698 0.3×	4.0k 1.6×	294	22.3k
Paul van der Valk Netherlands	80	5.8k 0.8×	1.1k 0.3×	1.4k 0.5×	1.2k 0.5×	5.4k 2.2×	252	19.5k
Edward J. Goetzl United States	94	13.6k 1.9×	2.3k 0.7×	1.5k 0.6×	3.7k 1.4×	1.9k 0.8×	380	26.6k
John D. Baxter United States	78	9.0k 1.2×	1.1k 0.3×	663 0.2×	1.2k 0.4×	1.4k 0.6×	265	19.4k
Edward T.H. Yeh United States	76	11.2k 1.6×	2.2k 0.6×	1.8k 0.6×	597 0.2×	5.3k 2.2×	195	22.1k

Countries citing papers authored by Barbara S. Slusher

Since Specialization

Citations

This map shows the geographic impact of Barbara S. Slusher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara S. Slusher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara S. Slusher more than expected).

Fields of papers citing papers by Barbara S. Slusher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara S. Slusher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara S. Slusher. The network helps show where Barbara S. Slusher may publish in the future.

Co-authorship network of co-authors of Barbara S. Slusher

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara S. Slusher. A scholar is included among the top collaborators of Barbara S. Slusher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara S. Slusher. Barbara S. Slusher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yannan, Ajit G. Thomas, A. Sharma, et al.. (2025). Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits. Neurotherapeutics. 22(6). e00759–e00759.

Uniyal, Ankit, Niyada Hin, Qian Xu, et al.. (2025). An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain–related behaviors in humanized mice. Science Translational Medicine. 17(829). eadw9446–eadw9446.

Fan, Jiawei, Tien-Chin Chang, Yao Shen, et al.. (2025). Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment. Advanced Biology. 9(10). e00738–e00738. 2 indexed citations

Li, Yannan, et al.. (2024). Dectin-1 as a therapeutic target for inflammatory bowel disease. Advances in pharmacology. 101. 237–264. 1 indexed citations

Kales, Stephen C., Xin Hu, Takashi Tsukamoto, et al.. (2024). Development of a high‐throughput dual‐stream liquid chromatography–tandem mass spectrometry method to screen for inhibitors of glutamate carboxypeptidase II. Rapid Communications in Mass Spectrometry. 39(S1). e9772–e9772. 2 indexed citations

Thomas, Ajit G., Niyada Hin, Lukáš Tenora, et al.. (2023). Neutral sphingomyelinase 2 inhibitors based on the pyrazolo[1,5-a]pyrimidin-3-amine scaffold. European Journal of Medicinal Chemistry. 259. 115674–115674. 2 indexed citations

Lee, Kyungho, Elizabeth A. Thompson, Chirag H. Patel, et al.. (2023). T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade. JCI Insight. 8(12). 14 indexed citations

Parveen, Sadiya, Jessica Shen, Shichun Lun, et al.. (2023). Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis. Nature Communications. 14(1). 7427–7427. 19 indexed citations

Lal, Bachchu, Rana Rais, Jesse Alt, et al.. (2023). Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma. Clinical Cancer Research. 29(20). 4209–4218. 4 indexed citations

10.

Hollinger, Kristen R., Pragney Deme, Shinji Sakamoto, et al.. (2022). Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice. Brain Behavior & Immunity - Health. 23. 100478–100478. 6 indexed citations

11.

Arab, Tanina, Emily R. Mallick, Yiyao Huang, et al.. (2021). Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms. Journal of Extracellular Vesicles. 10(6). e12079–e12079. 136 indexed citations

12.

Leone, Robert D., Liang Zhao, Judson M. Englert, et al.. (2019). Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 366(6468). 1013–1021. 813 indexed citations breakdown →

13.

Lemberg, Kathryn M., Liang Zhao, Ying Wu, et al.. (2019). The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 19(2). 397–408. 16 indexed citations

14.

Wang, Sabrina, Brad Poore, Jesse Alt, et al.. (2019). Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine. Clinical Cancer Research. 25(19). 5925–5936. 23 indexed citations

15.

Hollinger, Kristen R., Matthew D. Smith, Leslie A. Kirby, et al.. (2019). Glutamine antagonism attenuates physical and cognitive deficits in a model of MS. Neurology Neuroimmunology & Neuroinflammation. 6(6). 17 indexed citations

16.

Alt, Jesse, Marigo Stathis, Camilo Rojas, & Barbara S. Slusher. (2013). Glutamate carboxypeptidase II is not an amyloid peptide‐degrading enzyme. The FASEB Journal. 27(7). 2620–2625. 4 indexed citations

17.

Grunberg, Steven M., Barbara S. Slusher, & Hope S. Rugo. (2013). Emerging treatments in chemotherapy-induced nausea and vomiting.. PubMed. 11(2 Suppl 1). 1–18; quiz 2 p following 18. 20 indexed citations

18.

Wozniak, Krystyna M., K. Nomoto, Rena G. Lapidus, et al.. (2011). Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice. Cancer Research. 71(11). 3952–3962. 75 indexed citations

19.

Seltzer, Meghan J., Bryson D. Bennett, Avadhut D. Joshi, et al.. (2010). Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1. Cancer Research. 70(22). 8981–8987. 410 indexed citations

20.

Williams, Alistair J.K., et al.. (2001). Electroencephalogram analysis and neuroprotective profile of the N-acetylated-alpha-linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats.. PubMed. 299(1). 48–57. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact